Siva Krishna Muchakayala

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• A facile and eco-friendly simultaneous quantification LC-TQ-MS/MS approach for N-Nitroso Moxifloxacin and di-nitroso pyrrolopiperidine in Moxifloxacin tablets and eye drops
  Green Analytical Chemistry 2025 DOI: 10.1016/j.greeac.2024.100188
  +Save
• A novel LC-TQ-MS/MS method for quantifying mefenamic acid-NDSRI (N-nitroso drug substance-related impurity) in mefenamic acid tablet and pediatric suspension dosage forms: a comparative study with a cost-effective white, green, and blue UPLC method
  RSC Advances 2025 DOI: 10.1039/D4RA08425J
  +Save
• Strategic approaches to elevate quality and sustainability of NDSRIs method development: Synthesis and a simultaneous quantification study of multiple tamsulosin NDSRIs
  Microchemical Journal 2025 DOI: 10.1016/j.microc.2025.114065
  +Save
• Greenness assessment for the control of trace-level genotoxic process impurities in Vildagliptin by liquid chromatography with mass spectrometry
  Sustainable Chemistry and Pharmacy 2024 DOI: 10.1016/j.scp.2024.101811
  +Save
• Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone
  Biomedical Chromatography 2024 DOI: 10.1002/bmc.6001
  +Save
• Strategic Approaches to Elevate Quality and Sustainability in Drug Development: Comprehensive Pretomanid (PA-824) Chemical Stability study using QbD and Green Chemistry Principles
  Microchemical Journal 2024 DOI: 10.1016/j.microc.2024.110413
  +Save
• A novel and eco-friendly UPLC-ESI-MS method for the quantification of Aceclofenac-NDSRI (Nitroso Drug Substance Related Impurity) from Aceclofenac drug substance and combination formulations
  Sustainable Chemistry and Pharmacy 2024 DOI: 10.1016/j.scp.2024.101495
  +Save
• Synthesis and Trace-Level Quantification of Mutagenic and Cohort-of-Concern Ciprofloxacin Nitroso Drug Substance-Related Impurities (NDSRIs) and Other Nitroso Impurities Using UPLC-ESI-MS/MS─Method Optimization Using I-Optimal Mixture Design
  ACS Omega 2024 DOI: 10.1021/acsomega.3c05170
  +Save
• A sensitive ultra‐performance liquid chromatography‐tandem mass spectrometry method for the simultaneous quantification of assay and trace‐level genotoxic tosylate analogs (methyl and ethyl) in empagliflozin and its tablet dosage forms
  Biomedical Chromatography 2024 DOI: 10.1002/bmc.5755
  +Save
• Regulatory Perspective Reverse Engineering Analysis of the Mast Cell Stabilizer and the Histamine Receptor Antagonist (Olopatadine HCl): Instrumental and Classical Methods for Multiple Formulations
  ACS Omega 2023 DOI: 10.1021/acsomega.3c00311
  +Save